{"nct_id":"NCT01631552","title":"Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2012-12-17","start_date_type":"ACTUAL","primary_completion_date":"2019-03-01","primary_completion_date_type":"ACTUAL","completion_date":"2020-08-13","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GILD"]}